These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 1680655)
21. Pharmacokinetics and toxicokinetics of an orally active tripeptide, IRI-695, in animals. Adusumalli V; Corkum N; Jacala A; Mukherjee T; Goodlett D; Crowther J; McConnell I; Goldstein G Biopharm Drug Dispos; 1996 Jan; 17(1):25-41. PubMed ID: 8991489 [TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of medetomidine. Salonen JS Acta Vet Scand Suppl; 1989; 85():49-54. PubMed ID: 2571277 [TBL] [Abstract][Full Text] [Related]
23. Comparative kinetics of sematilide in four species. Hinderling PH; Dilea C; Koziol T; Millington G Drug Metab Dispos; 1993; 21(4):662-9. PubMed ID: 8104126 [TBL] [Abstract][Full Text] [Related]
24. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees. Riska PS; Joseph DP; Dinallo RM; Davidson WC; Keirns JJ; Hattox SE Drug Metab Dispos; 1999 Dec; 27(12):1434-47. PubMed ID: 10570025 [TBL] [Abstract][Full Text] [Related]
25. Disposition of vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in rats and dogs. He H; Tran P; Yin H; Smith H; Flood D; Kramp R; Filipeck R; Fischer V; Howard D Drug Metab Dispos; 2009 Mar; 37(3):545-54. PubMed ID: 19074976 [TBL] [Abstract][Full Text] [Related]
26. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys. Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of amezinium in rat and dog. Traut M; Brode E; Neumann B; Kummer H Arzneimittelforschung; 1981; 31(9a):1594-604. PubMed ID: 7197974 [TBL] [Abstract][Full Text] [Related]
28. Dose-independent pharmacokinetics of the cardioprotective agent dexrazoxane in dogs. Baldwin JR; Lewis RC; Phillips BA; Overmyer SK; Hatfield NZ; Narang PK Biopharm Drug Dispos; 1996 Aug; 17(6):541-50. PubMed ID: 8866044 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics, tissue distribution, and excretion of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3- dioxolane]platinum(II) in dogs. Cho YB; Kim KH; Kim DK Drug Metab Dispos; 1995 Nov; 23(11):1280-5. PubMed ID: 8591731 [TBL] [Abstract][Full Text] [Related]
30. Disposition of the antipsychotic agent CI-1007 in rats, monkeys, dogs, and human cytochrome P450 2D6 extensive metabolizers. Species comparison and allometric scaling. Feng MR; Loo J; Wright J Drug Metab Dispos; 1998 Oct; 26(10):982-8. PubMed ID: 9763403 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and tissue distribution of the new gastrokinetic agent cisapride in rat, rabbit and dog. Michiels M; Monbaliu J; Hendriks R; Geerts R; Woestenborghs R; Heykants J Arzneimittelforschung; 1987 Oct; 37(10):1159-67. PubMed ID: 3435588 [TBL] [Abstract][Full Text] [Related]
32. [Pharmacokinetics of AR-L 115 BS in rabbits and dogs]. Zimmer A; Hammer R Arzneimittelforschung; 1981; 31(1a):212-6. PubMed ID: 7195224 [TBL] [Abstract][Full Text] [Related]
33. Metabolic fate of the new cardiotonic denopamine in animals. 1st communication: absorption, distribution and excretion in the rat, rabbit and dog. Naito K; Furuuchi S; Yamada Y; Otsuka M; Harigaya S Arzneimittelforschung; 1986 Apr; 36(4):643-51. PubMed ID: 3718588 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of trospectomycin sulphate in healthy subjects after single intravenous and intramuscular doses. Nichols DJ; Bye A; Novak E Br J Clin Pharmacol; 1991 Aug; 32(2):255-7. PubMed ID: 1834145 [TBL] [Abstract][Full Text] [Related]
35. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys. Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675 [TBL] [Abstract][Full Text] [Related]
36. Interspecies prediction of human drug clearance based on scaling data from one or two animal species. Tang H; Hussain A; Leal M; Mayersohn M; Fluhler E Drug Metab Dispos; 2007 Oct; 35(10):1886-93. PubMed ID: 17646280 [TBL] [Abstract][Full Text] [Related]
37. Metabolic fate of the new anti-ulcer drug enprostil in animals. 1st communication: absorption, distribution and excretion in the mouse, rat and rabbit. Smith S; Teitelbaum P; Bowen L; Tomlinson R; Berry P; Yani A; Parnes H; Chaplin M Arzneimittelforschung; 1989 Mar; 39(3):335-41. PubMed ID: 2502986 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs. Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279 [TBL] [Abstract][Full Text] [Related]
39. Metabolism and excretion of trovafloxacin, a new quinolone antibiotic, in Sprague-Dawley rats and beagle dogs. Effect of bile duct cannulation on excretion pathways. Dalvie DK; Khosla NB; Navetta KA; Brighty KE Drug Metab Dispos; 1996 Nov; 24(11):1231-40. PubMed ID: 8937858 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys. Sugimoto T; Hayashi T; Okita A; Morino A Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]